account_balance

Investment manager · 13F filer · SEC CIK 1715579

Medicxi Ventures Management (Jersey) Ltd

Reported value$127Mas of Sep 30, 2026
Positions3 0 new, 0 sold out
Top 10 weight100.0%PHAT alone is 43%
FiledNov 233 days after quarter end

Portfolio · as of Sep 30, 2026

Where the money is

New or addedTrimmedHeld

This fund reports 3 stocks.

Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

Show the top 3 as a list
PHAT Phathom Pharmaceuticals Inc 43.0% HeldNAMS Newamsterdam Pharma Company 41.9% HeldAURA Aura Biosciences Inc 15.1% Held

What changed

Biggest moves since Jun 30, 2026

Filed Nov 2, 2026, compared with the Aug 4, 2026 filing
add_circleNew

None

arrow_upwardAdded

None

arrow_downwardTrimmed

None

remove_circleSold out

None

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate.

This is data, not investment advice. About StockToast